These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19464368)

  • 1. Biomarkers in neuropsychiatric diseases.
    Kang UJ
    Neurobiol Dis; 2009 Aug; 35(2):115-6. PubMed ID: 19464368
    [No Abstract]   [Full Text] [Related]  

  • 2. Central role of glia in disease research.
    Fields RD
    Neuron Glia Biol; 2010 May; 6(2):91-2. PubMed ID: 20959032
    [No Abstract]   [Full Text] [Related]  

  • 3. Proteomics and Neurodegenerative Disorders: Advancements in the Diagnostic Analysis.
    Puranik N; Yadav D; Yadav SK; Chavda VK; Jin JO
    Curr Protein Pept Sci; 2020; 21(12):1174-1183. PubMed ID: 32392110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Contemporary Neuroproteomic Techniques in Unravelling Neurological Disorders.
    Khurana M; Rahman SO; Najmi AK; Pottoo FH; Akhtar MS
    Curr Protein Pept Sci; 2020; 21(12):1146-1163. PubMed ID: 33148155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular biomarkers of neurodegeneration.
    Höglund K; Salter H
    Expert Rev Mol Diagn; 2013 Nov; 13(8):845-61. PubMed ID: 24151849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tear Biomarkers in Alzheimer's and Parkinson's Diseases, and Multiple Sclerosis: Implications for Diagnosis (Systematic Review).
    Król-Grzymała A; Sienkiewicz-Szłapka E; Fiedorowicz E; Rozmus D; Cieślińska A; Grzybowski A
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNAs as biomarkers of neurodegenerative disorders.
    Viswambharan V; Thanseem I; Vasu MM; Poovathinal SA; Anitha A
    Biomark Med; 2017 Feb; 11(2):151-167. PubMed ID: 28125293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Welcome to the 11th Volume of Biomarkers in Medicine.
    Wilson H
    Biomark Med; 2017 Jan; 11(1):1-3. PubMed ID: 27967208
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of proteomics in biomarker discovery: prognosis and diagnosis of neuropsychiatric disorders.
    Patel S
    Adv Protein Chem Struct Biol; 2014; 94():39-75. PubMed ID: 24629185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspective of neurochemistry in neurological disorders.
    Tang LC
    Adv Exp Med Biol; 1995; 363():1-13. PubMed ID: 7542429
    [No Abstract]   [Full Text] [Related]  

  • 11. Developing predictive biomarkers for dementia of Parkinson's disease.
    Caviness JN; Aarsland D
    Expert Rev Neurother; 2011 Dec; 11(12):1661-3. PubMed ID: 22091589
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurofilaments as biomarkers in neurological disorders.
    Khalil M; Teunissen CE; Otto M; Piehl F; Sormani MP; Gattringer T; Barro C; Kappos L; Comabella M; Fazekas F; Petzold A; Blennow K; Zetterberg H; Kuhle J
    Nat Rev Neurol; 2018 Oct; 14(10):577-589. PubMed ID: 30171200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral Biomarkers for Early Detection of Alzheimer's and Parkinson's Diseases.
    Htike TT; Mishra S; Kumar S; Padmanabhan P; Gulyás B
    Mol Neurobiol; 2019 Mar; 56(3):2256-2277. PubMed ID: 30008073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. News on the journal Neurological Sciences in 2017.
    Di Donato I; Federico A
    Neurol Sci; 2018 Jan; 39(1):15-21. PubMed ID: 29327225
    [No Abstract]   [Full Text] [Related]  

  • 15. Heterogeneity of the midbrain dopamine system: Implications for Parkinson disease.
    Hassan A; Benarroch EE
    Neurology; 2015 Nov; 85(20):1795-805. PubMed ID: 26475693
    [No Abstract]   [Full Text] [Related]  

  • 16. Application of electrophysiological tests in the study of neurological diseases with visual involvement.
    Rodriguez-Mena D; Almarcegui C; Dolz I; Pablo LE; Garcia-Martin E
    Arch Soc Esp Oftalmol; 2012 Oct; 87(10):311-4. PubMed ID: 23021227
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroproteomic profiling of human body fluids.
    Häggmark A; Schwenk JM; Nilsson P
    Proteomics Clin Appl; 2016 Apr; 10(4):485-502. PubMed ID: 26286680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins.
    Butterfield DA; Palmieri EM; Castegna A
    Expert Rev Proteomics; 2016; 13(3):259-74. PubMed ID: 26837425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of molecular imaging in the diagnosis and management of neuropsychiatric disorders.
    Shen LH; Tseng YC; Liao MH; Fu YK
    J Biomed Biotechnol; 2011; 2011():439397. PubMed ID: 21541178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultra-sensitive techniques for detecting neurological biomarkers: Prospects for early diagnosis.
    Kumar D; Hassan MI
    Biochem Biophys Res Commun; 2021 Dec; 584():15-18. PubMed ID: 34753063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.